Page last updated: 2024-10-28

idra 21 and Learning Disabilities

idra 21 has been researched along with Learning Disabilities in 1 studies

IDRA 21: modulates AMPA receptor desensitization ; structure given in first source

Learning Disabilities: Conditions characterized by a significant discrepancy between an individual's perceived level of intellect and their ability to acquire new language and other cognitive skills. These may result from organic or psychological conditions. Relatively common subtypes include DYSLEXIA, DYSCALCULIA, and DYSGRAPHIA.

Research Excerpts

ExcerptRelevanceReference
" From dose-response studies, it can be estimated that IDRA 21 is approximately 10-fold more potent than aniracetam in antagonizing alprazolam-induced learning deficit."1.297-Chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine S,S-dioxide (IDRA 21), a congener of aniracetam, potently abates pharmacologically induced cognitive impairments in patas monkeys. ( Costa, E; DiBella, M; Guidotti, A; Thompson, DM, 1995)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Thompson, DM1
Guidotti, A1
DiBella, M1
Costa, E1

Other Studies

1 other study available for idra 21 and Learning Disabilities

ArticleYear
7-Chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine S,S-dioxide (IDRA 21), a congener of aniracetam, potently abates pharmacologically induced cognitive impairments in patas monkeys.
    Proceedings of the National Academy of Sciences of the United States of America, 1995, Aug-15, Volume: 92, Issue:17

    Topics: Alprazolam; Animals; Benzothiadiazines; Conditioning, Operant; Discrimination, Psychological; Dose-R

1995